Overexpression of VEGF and Angiopoietin 2: A Key to High Vascularity of Hepatocellular Carcinoma?
- 1 June 2003
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 16 (6) , 552-557
- https://doi.org/10.1097/01.mp.0000071841.17900.69
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Spontaneous tumour rupture and prognosis in patients with hepatocellular carcinomaBritish Journal of Surgery, 2002
- Inhibition of angiopoietin-1 expression in tumor cells by an antisense RNA approach inhibited xenograft tumor growth in immunodeficient miceInternational Journal of Cancer, 2001
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- Biologic significance of angiopoietin-2 expression in human hepatocellular carcinomaJournal of Clinical Investigation, 1999
- Enhanced Expression of Thrombospondin–1 and Hypovascularity in Human CholangiocarcinomaHepatology, 1998
- Cell Type-Specific Expression of Angiopoietin-1 and Angiopoietin-2 Suggests a Role in Glioblastoma AngiogenesisThe American Journal of Pathology, 1998
- Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liverHepatology, 1998
- p53 Mutations in Human CancersScience, 1991
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989